Goldman Sachs Revises Estimates on Intuitive Surgical (ISRG)

Goldman Sachs updates its EPS estimates on Intuitive Surgical ISRG. In a note to clients, Goldman Sachs writes, "We are updating our FY2010, 2011, 2012, 2013 and 2014 EPS estimates for ISRG to $8.76, $9.92, $11.66, $13.42 and $15.08 from $8.73, $9.83, $11.41, $13.05 and $14.40. The changes are a result of higher pricing assumptions for Instruments in 2011. We do not view these changes as material, and there is no change to our investment thesis, rating or price target." Goldman Sachs maintains a Sell rating and $240 price target on ISRG. ISRG is trading at $261.49.